Results 231 to 240 of about 60,176 (280)

Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells. [PDF]

BMC Genet, 2019
Fecková B, Kimáková P, Ilkovičová L, Szentpéteriová E, Macejová M, Košuth J, Zulli A, Debeljak N, Hudler P, Jašek K, Kašubová I, Kubatka P, Solár P.   +12 more
europepmc   +1 more source

Continuous Erythropoietin Receptor Activator for the Treatment of Chronic Dialysis Patients with Renal Anemia in Daily Clinical Practice in Poland: A Non-Interventional, Multi-Center, Pragmatic NAVIGO Trial.

Nephron
Nowicki M, Drożdż M, Wajda J, Klatko W, Segiet-Święcicka A.   +4 more
europepmc   +1 more source

The Lung-Kidney Axis: A Coordinated Regulation of Oxygen Sensing and Erythropoiesis. [PDF]

Biomedicines
Al Rajeh AM.
europepmc   +1 more source

Erythropoietin drug targets and cancer risk: A two-sample Mendelian randomization study. [PDF]

Medicine (Baltimore)
Chen H, Yang X, Huang T, Zhou H.
europepmc   +1 more source

A minimal mathematical model of red blood cell homeostasis in anemia. [PDF]

PLoS Comput Biol
Dor H, Alon U.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immunolocalization of Erythropoietin and Erythropoietin Receptor in Vestibular Schwannoma

Acta Oto-Laryngologica, 2001
Vestibular schwannomas constitute approximately 6% of intracranial tumors. Apart from the association with neurofibromatosis-2 (NF-2), where a defect in chromosome 22 has been identified, the pathogenesis of sporadic vestibular schwannomas is largely unknown.
D G, Dillard, G, Venkatraman, C, Cohen, J, Delgaudio, A A, Gal, D E, Mattox   +5 more
exaly   +3 more sources

Erythropoietin and Erythropoietin Receptor

Growth Factors, 1999
(1999). Erythropoietin and Erythropoietin Receptor. Growth Factors: Vol. 17, No. 1, pp. 25-35.
P A, Tilbrook, S P, Klinken
openaire   +2 more sources

The erythropoietin receptor

The International Journal of Biochemistry & Cell Biology, 1999
The erythropoietin (epo) receptor is a member of the cytokine receptor family. It is expressed almost exclusively on erythroid precursor cells and controls the development of red blood cells. The epo receptor has no intrinsic kinase activity, but binds intracellular tyrosine kinases to elicit its signals.
P A, Tilbrook, S P, Klinken
openaire   +2 more sources

Erythropoietin and Erythropoietin Receptor in Colorectal Cancer

International Journal of Surgical Pathology, 2008
Erythropoietin via erythropoietin receptor effectively prevents anemia, giving reasons for a clinical use of erythropoietin in patients with colorectal cancers. However, erythropoietin seems to promote survival of the neoplastic cells in hypoxic environment.
Anna M, Chabowska, Mariola, Sulkowska, Adrian, Chabowski, Andrzej, Wincewicz, Mariusz, Koda, Stanislaw, Sulkowski   +5 more
openaire   +2 more sources

The erythropoietin receptor

Seminars in Oncology, 2001
Erythropoietin (EPO) is the primary regulator of erythropoiesis, and promotes the survival, proliferation, and differentiation of erythroid progenitor cells. The EPO receptor belongs to the same family of receptors as growth hormone, granulocyte-colony stimulating factor, granulocyte macrophage-colony stimulating factor, and some interleukins.
openaire   +2 more sources